| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CASI Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 380,645 | 25 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465922065285-zhou-quan-2022-05-25 | CASI Pharmaceuticals, Inc. | 25 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 16:24 |
| /report/000110465921081997-zhou-quan-2021-06-15 | CASI Pharmaceuticals, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 16:02 |